Algül, Hana
TUM Klinikum · Technical University of Munich
11 papers on CoChatORCID 0000-0002-5067-7031
Most cited papers
- Verified
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy
Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism
Cited by 5,894
- Verified
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine
PARP inhibition in cancer therapyPancreatic and Hepatic Oncology Research
Cited by 2,302
- Verified
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell
Pancreatic and Hepatic Oncology ResearchCytokine Signaling Pathways and Interactions
Cited by 862
- Verified
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Ruess, D. A., Heynen, G. J., Ciecielski, K. J., Ai, J., Berninger, A., Kabacaoglu, D., Görgülü, K., Dantes, Z., Wörmann, S. M., Diakopoulos, K. N., et al. (2018) · Nature Medicine
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 370
- Verified
Variants in CPA1 are strongly associated with early onset chronic pancreatitis
Witt, H., Beer, S., Rosendahl, J., Chen, J.-M., Chandak, G. R., Masamune, A., Bence, M., Szmola, R., Oracz, G., Macek, M., et al. (2013) · Nature Genetics
Pancreatitis Pathology and TreatmentPancreatic and Hepatic Oncology Research
Cited by 305
- Verified
Overall survival results from the POLO trial: A Phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer
Kindler, H. L., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2022) · Journal of Clinical Oncology
PARP inhibition in cancer therapyPancreatic and Hepatic Oncology Research
Cited by 244
- Verified
Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice
Quinton, L. J., Blahna, M. T., Jones, M. R., Allen, E., Ferrari, J. D., Hilliard, K. L., Zhang, X., Sabharwal, V., Algül, H., Akira, S., et al. (2012) · Journal of Clinical Investigation
NF-κB Signaling PathwaysCytokine Signaling Pathways and Interactions
Cited by 84
- Verified
A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging
Kaissis, G., Ziegelmayer, S., Lohöfer, F., Algül, H., Eiber, M., Weichert, W., Schmid, R., Friess, H., Rummeny, E., Ankerst, D., et al. (2019) · European Radiology Experimental
Radiomics and Machine Learning in Medical ImagingMRI in cancer diagnosis
Cited by 79
- Verified
A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy
Kaissis, G., Ziegelmayer, S., Lohöfer, F., Steiger, K., Algül, H., Muckenhuber, A., Yen, H.-Y., Rummeny, E., Friess, H., Schmid, R., et al. (2019) · PLOS ONE
Radiomics and Machine Learning in Medical ImagingPancreatic and Hepatic Oncology Research
Cited by 76
- Verified
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Frank, K. J., Mulero-Sánchez, A., Berninger, A., Ruiz-Cañas, L., Bosma, A., Görgülü, K., Wu, N., Diakopoulos, K. N., Kaya-Aksoy, E., Ruess, D. A., et al. (2022) · Cell Reports Medicine
Pancreatic and Hepatic Oncology ResearchProtein Kinase Regulation and GTPase Signaling
Cited by 40
- Verified
Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death
Conradt, L., Henrich, A., Wirth, M., Reichert, M., Lesina, M., Algül, H., Schmid, R. M., Krämer, O. H., Saur, D., & Schneider, G. (2013) · International Journal of Cancer
Cancer-related Molecular PathwaysPancreatic and Hepatic Oncology Research
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free